Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Hindustan Bio Sciences Ltd

NSE: HINDBIO · BSE: 532041 · Pharmaceuticals & Biotechnology · 10 announcements

Share price
₹7.10
Market cap
₹7.28 Cr
Revenue (annual)
₹0.74 Cr
Net profit (annual)
₹-0.08 Cr
P/E (TTM)
-35.3×Sector 47.3×
Promoter holding
12.19%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:31 IST BSE
Annual General Meeting

Hindustan Bio Sciences Annual General Meeting

Hindustan Bio Sciences Limited has issued a notice for its 34th Annual General Meeting to be held on September 30, 2026, in Hyderabad.

18:21 IST BSE
Annual Report

Hindustan Bio Sciences Annual Report

Hindustan Bio Sciences Ltd submitted its 34th Annual Report for FY 2025-26, containing the AGM notice proposing a scheme of capital reduction.

16:42 IST BSE
Merger & Restructuring

Hindustan Bio Sciences Merger & Restructuring

Hindustan Bio Sciences Ltd announced a capital reduction scheme to set off accumulated losses against its share capital. No cash consideration is paid to shareholders.

21:36 IST BSE
Board Meeting Date

Hindustan Bio Sciences Board Meeting Date

Hindustan Biosciences scheduled a board meeting for August 31, 2026, to discuss the 34th AGM notice and a proposed scheme of share capital reorganization.

13:24 IST BSE
Board Meeting Date

Hindustan Bio Sciences Board Meeting Date

Hindustan Bio Sciences Ltd scheduled a board meeting for July 31, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.

18:50 IST BSE
Financial Results

Hindustan Bio Sciences Financial Results

Hindustan Bio Sciences Ltd approved its audited financial results for the year ended March 31, 2026. The board also re-appointed Mr. GBK Viswanadham as Internal Auditor.

16:18 IST BSE
Other Announcement

Hindustan Bio Sciences Other Announcement

Hindustan Bio Sciences submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirmed compliance with SEBI regulations with no adverse observations.

15:44 IST BSE
Board Meeting Date

Hindustan Bio Sciences Board Meeting Date

Hindustan Bio Sciences scheduled a board meeting on May 30, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.